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ABSTRACT OF DISSERTATION 
 
 
 
MALADAPTIVE PERSONALITY TRAITS AND HEALTH BEHAVIORS,  
HEALTH PERCEPTIONS, AND INFLAMMATORY BIOMARKERS  
IN OLDER ADULTS 
 
Traits from dimensional models of normal-range personality have been shown to 
predict physical health outcomes including health behaviors, health perceptions, disease, 
and mortality. Maladaptive traits of personality disorders may predict even more variance 
in physical health indicators. Dimensional models of maladaptive personality traits are 
replacing categorical models of personality disorder, and the five-factor model of 
personality disorder (FFMPD) has been shown to be a useful dimensional model of 
maladaptive traits. However, there has been little work investigating the criterion validity 
of the FFMPD for predicting physical health indicators. The present study examines 
FFMPD scales in the prediction of health behaviors, heath perceptions, and inflammatory 
biomarkers across two timepoints in a large, representative community sample of older 
adults. Findings indicate that the FFMPD scales explain a moderate amount of variance 
in the physical health variables across time. Exploratory analyses indicate that the 
FFMPD traits have incremental validity over covariates, normal-range personality traits, 
and categorical personality disorders. Results are considered in the broader context of the 
personality and health literature and future research directions are discussed.  
 
KEYWORDS: Personality traits, physical health, aging, five-factor model, personality 
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CHAPTER 1.  INTRODUCTION 
Over 50% of Americans suffer from chronic health conditions (Kung, Hoyert, Xu, 
& Murphy, 2008). A well-established base of research demonstrates that personality is an 
important predictor of health outcomes, including physical disease, health functioning, 
and longevity (Friedman & Kern, 2014; Ozer & Benet-Martinez, 2006; T. W. Smith, 
Williams, & Segerstrom, 2015; Turiano, Chapman, Gruenewald, & Mroczek, 2015). The 
impact of the adaptive personality trait domain of conscientiousness, for example—one 
of five domains from the five-factor model (FFM) of personality—has been shown to 
have a larger effect on mortality than socioeconomic status (Roberts, Kuncel, Shiner, 
Caspi, & Goldberg, 2007). Maladaptive personality traits that define personality 
disorders may have an even larger connection with health outcomes than do "normal" 
ranges of the five domains of the FFM (Gleason, Weinstein, Balsis, & Oltmanns, 2014). 
Personality disorders as defined by the traditional Diagnostic and Statistical Manual of 
Mental Disorders (DSM) have been associated with healthcare over-utilization, risk for 
chronic health issues, poor treatment adherence, and psychopathology (Pietrzak, Wagner, 
& Petry, 2007; Skodol et al., 2005; Zanarini, Frankenburg, Hennen, Reich, & Silk, 2005). 
Personality disorder classification, however, is undergoing a significant change 
from a categorical model, based on the traditional DSM personality disorder types, to a 
dimensional model consisting of five maladaptive personality trait domains (American 
Psychiatric Association, 2013; Widiger & Trull, 2007). The five trait domains included in 
Section III of DSM-5 for emerging measures and models include negative affectivity, 
detachment, psychoticism, antagonism, and disinhibition. DSM-5 stated that, “these five 
broad domains are maladaptive variants of the five domains of the extensively validated 
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and replicated personality model known as the 'Big Five' or Five Factor Model of 
personality” (APA 2013, p. 773).  
The FFM is a compelling framework through which to understand both normative 
personality and maladaptive personality/personality disorders. It consists of the five 
broad domains of neuroticism, extraversion, openness, agreeableness, and 
conscientiousness. Originally based on the representation of personality terms in 
language, the FFM is an integrative framework that accommodates scales from 
alternative dimensional models of personality (O'Connor, 2002) and provides a cohesive 
nomenclature for research (Goldberg, 1993; John, Naumann, & Soto, 2008; Ozer & 
Reise, 1994). The five factors have well documented childhood antecedents (Caspi, 
Roberts, & Shiner, 2005; Mervielde, De Clercq, De Fruyt, & Van Leeuwen, 2005), 
empirical support across eastern and western cultures (Allik, 2005) and a demonstrated 
temporal stability across the lifespan (Roberts & DelVecchio, 2000). The domains of the 
FFM have also demonstrated predictive validity for a variety of consequential life 
outcomes such as career success, criminal activity, happiness, psychopathology, marital 
failure and success, and longevity (Ozer & Benet-Martinez, 2006; Roberts et al., 2007). 
Beginning with hypotheses by Widiger, Trull, Clarkin, Sanderson, and Costa 
(1994), it was proposed that, in addition to its usefulness for understanding normal ranges 
of personality, the FFM might also be a useful framework for the study of personality 
disorder. Resulting empirical work (e.g., Lawton, Shields, & Oltmanns, 2011; Miller, 
2012; Samuel, Edmundson, & Widiger, 2011; Trull, Widiger, Lynam, & Costa, 2003) has 
shown that the FFM description of personality disorder has strong convergent validity 
with clinical measures of personality disorder. Meta-analyses of this research have 
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supported the FFM/personality disorder coordination (Samuel & Widiger, 2008; 
Saulsman & Page, 2004), as have qualitative reviews of this research (e.g., Clark, 2007; 
Livesley, 2001). The FFM descriptions of personality disorder have been shown to 
correlate as highly with measures of personality disorder as measures of personality 
disorder correlate amongst themselves (Trull et al., 2003). In order to extend this 
research, Widiger, Lynam, and colleagues (Lynam, 2012; Widiger, Lynam, Miller, & 
Oltmanns, 2012) introduced new measures of personality disorder that were developed 
creating scales assessing maladaptive variants of respective FFM facets that assess each 
respective personality disorder. For example, the Five Factor Obsessive-Compulsive 
Inventory (FFOCI; Samuel, Riddell, Lynam, Miller, & Widiger, 2012) includes 12 
subscales, assessing obsessive-compulsive personality variants of FFM conscientiousness 
(i.e., Perfectionism, Fastidiousness, Punctiliousness, Workaholism, Doggedness, and 
Ruminative Deliberation), introversion (i.e., Detached Coldness and Risk Aversion), 
neuroticism (i.e., Excessive Worry); and low openness (i.e., Constricted, Inflexibility, and 
Dogmatism). These “FFMPD” measures are thus assessing maladaptive variants of 
normal range personality traits, which is an advantage because they are grounded in an 
already extensive amount of empirical support that has been gathered regarding the 
normal-range FFM. 
1.1 PERSONALITY, HEALTH BEHAVIORS, AND HEALTH PERCEPTIONS 
Personality has been associated with physical health behaviors, biomarkers of 
inflammation, physical diseases, and mortality (Bogg & Roberts, 2004; T. W. Smith et 
al., 2015; Turiano et al., 2015). FFM personality traits explain a significant amount of 
variance in physical health behaviors and health outcomes (Strickhouser, Zell, & Krizan, 
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2017). In particular, FFM personality traits have been associated with two frequently 
used measures of health behaviors: the Health Behavior Checklist (HBCL) (Vickers, 
Conway, & Hervig, 1990) and the Health Status Inventory (HSI) (Hays & Morales, 
2001). The HBCL contains four subscales: Wellness Maintenance, Accident Control, 
Traffic Risk, and Substance Risk. Across several studies, conscientiousness has emerged 
as a robust predictor of these scales (more Wellness Maintenance and Accident Control, 
less Traffic Risk and Substance Risk) (Booth-Kewley & Vickers, 1994; Chuah, Drasgow, 
& Roberts, 2006; Crede, Harms, Niehorster, & Gaye-Valentine, 2012; Wasylkiw & 
Fekken, 2002). Extraversion and agreeableness often display relationships with the 
HBCL subscales (extraversion correlating with more Traffic Risk and Substance Risk, 
agreeableness with less Traffic Risk and more Accident Control), but these relationships 
have been smaller and less consistent. Even across multiple brief measures of the FFM, 
the domains from each measure explain a medium amount of variance (> R = .30) in the 
Wellness Maintenance, Traffic Risk, and Substance Risk subscales of the HBCL, and a 
smaller amount of variance in the Accident Control subscale (Crede et al., 2012). In a 
longitudinal study of 477 participants across three years, increases in the 
conscientiousness domain across time were associated with increases in positive health 
behaviors on the HBCL (Takahashi, Edmonds, Jackson, & Roberts, 2013). Facets of the 
FFM (i.e., subscale traits more specific than FFM domain-level traits) can provide more 
nuanced information about personality-health relationships: In a facet-level study of 
conscientiousness and health behaviors, the Impulse Control facet was moderately 
associated with Substance Risk and Traffic Risk and the Industriousness facet was 
moderately associated with Wellness Maintenance (Edmonds, Bogg, & Roberts, 2009). 
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Together, these studies indicate that conscientiousness is the most robust FFM domain 
associated with health behaviors, with other domains also having relationships with 
health behaviors that may vary with measure and facet within the domain.  
 In addition to health behaviors, general health perceptions have been associated 
with FFM personality traits (Wasylkiw & Fekken, 2002). General health perceptions are 
an important piece of physical health because they have been shown to be associated with 
mortality above and beyond more objective measures of physical health (DeSalvo, 
Bloser, Reynolds, He, & Muntner, 2006). Neuroticism has been associated, in particular, 
with worse perceptions of physical functioning (King, Jackson, Morrow-Howell, & 
Oltmanns, 2015), and extraversion, agreeableness, conscientiousness, and openness have 
been associated with the HSI total score (including emotional functioning scales) (Powers 
& Oltmanns, 2013). In a community sample of 698 older adults on Medicare, currently 
facing physical health problems and actively receiving treatment for health conditions, 
there were no significant associations between the FFM domains and general physical 
health perceptions (Löckenhoff, Sutin, Ferrucci, & Costa, 2008). However, in a second 
sample of 393 slightly younger and healthier community older adults, the authors found 
that neuroticism and conscientiousness were associated with general health perceptions 
(neuroticism negatively and conscientiousness positively). At the facet level, Löckenhoff 
et al. (2008) found that, in both samples, anxiousness, depressiveness, and vulnerability 
(from neuroticism) were associated with role limitations due to physical problems and 
lower general health perceptions and activity (from extraversion) and self-discipline 
(from conscientiousness) were both associated with better perceptions of physical 
functioning and general health perceptions. In the younger sample, positive emotions 
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(from extraversion) and order (from conscientiousness) were also associated with better 
general health perceptions. Longitudinally, Takahashi et al. (2013) found that domain-
level conscientiousness predicted more positive general health perception scores as well 
as increases in general health perceptions in a sample of 477 adults across a period of 
three years.  
 DSM personality disorders have also been associated with physical health 
problems. For example, personality disorders have been associated with higher rates of 
obesity, cardiovascular disease, and arthritis (Dixon-Gordon, Whalen, Layden, & 
Chapman, 2015; El-Gabalawy, Katz, & Sareen, 2010; Powers & Oltmanns, 2012). There 
are fewer studies on personality disorders, health behaviors, and health perceptions than 
there are on FFM traits and these constructs. However, several studies have documented 
important associations: DSM personality disorder measured by semi-structured interview 
predicted HSI Physical Functioning, Role Limitations due to Physical Problems, Pain, 
Energy/Fatigue, and General Health Perceptions over and above covariates, including 
major depressive disorder, across six months (Powers & Oltmanns, 2012). In a sample of 
16,884 older adults, five DSM personality disorders predicted physical health-related 
quality of life (PHRQoL): Three of them (obsessive-compulsive, dependent, and 
paranoid) were associated with PHRQoL over and above psychosocial covariates (Holzer 
& Huang, 2019).  
1.2 PERSONALITY AND INSOMNIA 
 Studies of FFM personality traits and insomnia have been increasing in number. 
Each domain has been associated with insomnia symptoms, with neuroticism (Blanken et 
al., 2019; Calkins, Hearon, Capozzoli, & Otto, 2013; Emert, Tutek, & Lichstein, 2017; 
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Fang et al., 2019; Gamaldo et al., 2019; Hintsanen et al., 2014; Huang, Peck, Mallya, 
Lupien, & Fiocco, 2016; Kim et al., 2015; Otaka et al., 2019; Ren et al., 2019; Stephan, 
Sutin, Bayard, Krizan, & Terracciano, 2018; van de Laar, Leufkens, Bakker, Pevernagie, 
& Overeem, 2017) and conscientiousness (Emert et al., 2017; Gamaldo et al., 2019; 
Hintsanen et al., 2014; Huang et al., 2016; Kim et al., 2015; Stephan et al., 2018; van de 
Laar et al., 2017) showing the most robust associations (neuroticism with more insomnia 
symptoms and conscientiousness with fewer insomnia symptoms), and extraversion 
(Fang et al., 2019; Hintsanen et al., 2014; Stephan et al., 2018; van de Laar et al., 2017), 
openness (Gamaldo et al., 2019), and agreeableness (Hintsanen et al., 2014) obtaining 
less consistent associations with insomnia symptoms. Large and/or longitudinal studies 
have shown particularly strong evidence for associations between neuroticism (Blanken 
et al., 2019; Hintsanen et al., 2014; Kim et al., 2015; Ren et al., 2019), conscientiousness 
(Kim et al., 2015; Stephan et al., 2018), and extraversion (Stephan et al., 2018) and 
insomnia symptoms. At the facet level, Gamaldo and colleagues (2019) found specific 
associations with insomnia for the following facets of the Big Five Inventory (John et al., 
2008), which has two facets per FFM domain: Anxiety and Depression (from 
neuroticism), Assertiveness and Activity (extraversion), Self-Discipline 
(conscientiousness), and Aesthetics (openness). Using a short version of the NEO-
Personality Inventory-Revised (NEO PI-R; Costa & McCrae, 1992), Kim and colleagues 
(2015) found positive correlations of insomnia with anxiousness, angry hostility, 
depressiveness, self-consciousness, impulsiveness, and vulnerability (from neuroticism), 
and feelings (from openness), and negative correlations of insomnia with gregariousness, 
activity, and positive emotions (extraversion), values (openness), trust, 
8 
 
straightforwardness and compliance (agreeableness), and competence, dutifulness, and 
self-discipline (conscientiousness).  
 Personality disorders have also been associated with insomnia, although the 
literature on personality disorders and insomnia is smaller (J. R. Oltmanns, 2019). 
Borderline personality features, in particular, have consistently been associated with self-
reported insomnia symptoms in large samples at moderate effect sizes (DeShong & 
Tucker, 2019; Grove, Smith, Crowell, & Ellis, 2017; Harty, Duckworth, Thompson, 
Stuewig, & Tangney, 2010; J. R. Oltmanns, Weinstein, & Oltmanns, 2014; Plante, 
Frankenburg, Fitzmaurice, & Zanarini, 2013; Selby, 2013; Van Veen, Karsten, & Lancel, 
2017). Further, borderline personality features remain associated with insomnia 
symptoms when statistically controlling for other personality disorder features and forms 
of psychopathology, such as major depression (Harty et al., 2010; J. R. Oltmanns et al., 
2014). Insomnia symptoms have also been documented in antisocial personality disorder 
(Kamphuis, Karsten, de Weerd, & Lancel, 2013; Ruiter, Lichstein, Nau, & Geyer, 2012; 
Semiz et al., 2008; Van Veen et al., 2017). Other personality disorders have less frequent 
and less consistent relationships with insomnia, including avoidant, obsessive-
compulsive, dependent, schizotypal, and schizoid personality features (Petrov, Emert, & 
Lichstein, 2019; Ruiter et al., 2012).  
1.3 PERSONALITY AND BIOMARKERS OF INFLAMMATION 
FFM personality trait domains have also been associated with biomarkers of 
inflammation (Luchetti, Barkley, Stephan, Terracciano, & Sutin, 2014; Wagner et al., 
2019). In particular, the relationship between conscientiousness and lower levels of C-
reactive protein (CRP) and interleukin-6 (IL-6) have been most robust (Allen & Laborde, 
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2017; Luchetti et al., 2014). Neuroticism has shown relationships with higher levels of 
CRP and IL-6 (Armon, Melamed, Shirom, Berliner, & Shapira, 2013; Graham et al., 
2018; Sutin et al., 2010), but this relationship has failed to replicate several times (Allen 
& Laborde, 2017; Marsland et al., 2007; Mottus, Luciano, Starr, Pollard, & Deary, 2013; 
Wagner et al., 2019). Extraversion, openness, and agreeableness have also shown 
relationships with biomarkers, but they have been less frequent and less replicated (Allen 
& Laborde, 2017; Chapman et al., 2009; Luchetti et al., 2014; Mottus et al., 2013; Sutin 
et al., 2010). At the facet-level, angry hostility and impulsivity (from neuroticism) were 
both significantly associated with higher levels of CRP and IL-6, and activity (from 
extraversion) and order and self-control (from conscientiousness) were all associated with 
lower levels of CRP and IL-6 (Sutin et al., 2010). Sutin and colleagues also found that all 
other facets of NEO-PI-R conscientiousness (competence, dutifulness, achievement 
striving, and deliberation) were negatively associated with IL-6, and vulnerability (from 
neuroticism) was positively associated with IL-6. The activity facet (from extraversion) 
was also uniquely associated with inflammatory markers (Chapman et al., 2009).  
There may be explanations for inconsistency in associations between FFM traits 
and inflammatory biomarkers. First, the associations are typically small and would then 
require very large sample sizes to be significant, which are not always used. Second, brief 
measures of FFM traits are often used in this research, and are often only examined at the 
domain-level for that reason. Measures with more items also provide more reliable 
assessments, which suffer less from attenuation (providing more robust statistical 
associations). Further, longer measures allow for the examination of specific facet-level 
associations. If facets within FFM domains have varying relationships with inflammatory 
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biomarkers, not examining the facet-level may obfuscate more specific facet-level 
relationships and muddy findings at the domain-level. The present study examines 
associations between personality and inflammatory biomarkers in a relatively large 
sample with facet-level assessments.  
There are fewer studies on DSM personality disorders and inflammatory 
biomarkers. Further, the studies that do exist are often cross-sectional and examine small 
samples, which are less informative than large sample-size, longitudinal studies. 
However, associations have been found between schizotypal personality disorder and 
CRP (Gong et al., 2019) and general personality disorder and CRP (Hinze-Selch, 
Daubener, Erdag, & Wilms, 2010) in larger samples (i.e., between N = 100 and N = 900). 
While there are fewer DSM personality disorder studies on biomarkers, there are 
several studies on other maladaptive personality traits and inflammatory biomarkers. 
“Type D” personality (a combination of negative affect and social inhibition) has been 
linked to IL-6 (Mommersteeg et al., 2012). However, in a sample of N = 712 community 
participants, Type D participants did not differ from non-Type D participants in CRP or 
IL-6 (van Dooren et al., 2016). Trait hostility has also been linked with CRP and IL-6 
(Boisclair Demarble, Moskowitz, Tardif, & D'Antono, 2014; Elovainio et al., 2011; 
Marsland, Prather, Petersen, Cohen, & Manuck, 2008; Mwendwa et al., 2013; T. W. 
Smith, Uchino, Bosch, & Kent, 2014), trait depressiveness with CRP (Mwendwa et al., 
2013), alexithymia with CRP (De Berardis et al., 2008), and impulsivity with IL-6 (Isung 
et al., 2014). However, some findings have failed to replicate (Kojima et al., 2014) and 
the literature is small. These studies are far from definitive and further research is needed 
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with large longitudinal samples and maladaptive personality traits measured within a 
coherent multidimensional framework, such as the FFM.  
1.4 THE PRESENT STUDY 
The current study examines multiple measures of maladaptive variants of the 
FFM (i.e., the FFBI, FFOCI, and FFAvA), as well as measures of DSM personality 
disorders (the Multi-Source Assessment of Personality Pathology) (T. F. Oltmanns & 
Turkheimer, 2006) and normal-range FFM traits (the NEO-PI-R) (Costa & McCrae, 
1992) to explore longitudinal relationships with health behaviors, health perceptions, and 
biomarkers of inflammation. The FFMPD measures have not yet been examined 
longitudinally in the prediction of health outcomes. It is therefore important to examine 
the connection between FFMPD measures and physical health outcomes, which are 
measured in the present study using subjective assessments (the HBCL and HSI) as well 
as biological measures of stress and inflammation (CRP and IL-6). Physical health 
behaviors and perceptions are also assessed via informant-reports, which will add, in 
addition to biological markers, a multi-method aspect to the assessment of health 
behaviors and perceptions. Results from the present study will improve knowledge of 
how personality relates to physical health and could inform clinical interventions for 
treating maladaptive personality styles, such as those already developed for increasing 
conscientiousness (Magidson, Roberts, Collado-Rodriguez, & Lejuez, 2014) and 
decreasing neuroticism (Barlow et al., 2011). 
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CHAPTER 2.  METHOD 
2.1 PROCEDURE 
Beginning in 2007 and over the course of three and a half years, 1,630 
participants were recruited from the St. Louis area using listed phone numbers purchased 
from a private sampling company. The Kish Method was used to determine who the 
target was in the household (Kish, 1949). Since baseline, there have been 12 follow-ups, 
with four being full-scale in-person assessments. At full-scale assessments, participants 
provide informed consent, complete semi-structured interviews for personality pathology 
and common mental disorders, a life narrative interview, and a battery of self-report 
questionnaires about their personality, health, and relationships. Participants are 
compensated $60 for the three-hour full-scale assessment. Wave 1 data for the present 
study were collected at the third full-scale in-person assessment (overall, the tenth 
follow-up assessment). Wave 2 data were collected at a fourth in-person assessment, two 
years after Wave 1. At Waves 1 and 2 for the present study, participants also nominated 
an “informant” (i.e., someone who “knows them best”), to also complete brief 
questionnaires about target participant’s health. 
2.2 PARTICIPANTS 
Wave 1 was completed by N = 1,060 participants (Mage = 65.9 years, SD = 2.9 
years), with 791 consenting to a blood draw for biomarker collection. Wave 2 was 
completed by n = 937 participants, with 828 consenting to the blood draw for biomarker 
collection. Participants were 55% female, 66% white, 32% black, and 2% other. Health 
questionnaire data were collected from N = 849 informants at Wave 1 and from n = 562 
informants at Wave 2. Informants were 51% romantic partners, 26% other family 
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members, 21% friends, and 2% other. On average, informants had known the target 
participants for 38 years. 
2.3 MEASURES 
NEO-Personality Inventory-Revised (NEO-PI-R). The NEO-Personality 
Inventory-Revised (Costa & McCrae, 1992) is a widely validated 240-item self-report 
measure that provides an assessment of the five domains of the FFM (neuroticism, 
extraversion, openness, agreeableness, and conscientiousness), as well as six lower-order 
facets of each domain, for a total of 30 facet-level subscales. Items are answered on a 
Likert-scale from 1 (strongly disagree) to 5 (strongly agree). Median coefficient alpha 
for the NEO-PI-R facets at Wave 1 was .73 and ranged from .58 (Excitement-Seeking) to 
.84 (Depression). Median coefficient alpha at Wave 2 was .72 and ranged from .61 
(Excitement-Seeking) to .85 (Depression). 
Multi-Source Assessment of Personality Pathology (MAPP). The Multi-Source 
Assessment of Personality Pathology (T. F. Oltmanns & Turkheimer, 2006) is an 80-item 
self-report measure of the diagnostic criteria of the ten DSM personality disorder types. 
Criteria are translated into lay language and participants rate themselves on each criterion 
from 0 (I am never like this) to 5 (I am always like this). The measure has been shown to 
provide a reliable estimate of the symptoms of the DSM personality disorders (T. F. 
Oltmanns & Turkheimer, 2006). Coefficient alphas for the MAPP scales at Wave 1 were 
.68 (Borderline), .65 (Obsessive-Compulsive), and .82 (Avoidant). Coefficient alphas for 
the MAPP scales at Wave 2 were .72 (Borderline), .68 (Obsessive-Compulsive), and .81 
(Avoidant). 
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Five-Factor Model Personality Disorder Scales (FFMPD). Three FFMPD 
measures used in the current study were chosen based on personality pathology 
prevalence rates in the SPAN sample at baseline. Borderline, avoidant, and obsessive-
compulsive personality disorders showed higher prevalence than other personality 
disorders. Measuring maladaptive variants of the FFM in the present study are the Five 
Factor Borderline Inventory (FFBI; Mullins-Sweatt et al., 2012), the Five-Factor 
Obsessive-Compulsive Inventory (FFOCI; Samuel et al., 2012), and the Five-Factor 
Avoidant Assessment (FFAvA; Lynam, Loehr, Miller, & Widiger, 2012). Additional 
studies on these measures have expanded support for their construct validity (e.g., Carter, 
Guan, Maples, Williamson, & Miller, 2016; Crego, Samuel, & Widiger, 2015; DeShong, 
Lengel, Sauer-Zavala, O'Meara, & Mullins-Sweatt, 2015; Haas & Miller, 2015). 
Abbreviated versions of these instruments were used, for which there is published 
validation evidence (e.g., DeShong, Mullins-Sweatt, Miller, Widiger, & Lynam, 2016; 
Griffin et al., 2018). These studies have documented that the abbreviated versions (with 
four-item scales) replicate closely the results obtained for the original versions. FFMPD 
items are rated on a Likert-type scale from 1 (strongly disagree) to 5 (strongly agree). 
Table 1 lists the FFMPD scales arranged by their assessment of maladaptive 
neuroticism, extraversion, and conscientiousness. The FFBI-SF is a 48-item self-report 
measure assessing twelve maladaptive variant scales of FFM facets, with seven from 
neuroticism (Anxious Uncertainty, Dysregulated Anger, Despondence, Self-Disturbance, 
Behavioral Dysregulation, Affective Dysregulation, and Fragility), three from 
antagonism (Distrustfulness, Manipulativeness, and Oppositional), one from openness 
(Dissociative Tendencies), and one from low conscientiousness (Rashness). The FFOCI-
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SF is a 48-item self-report measure assessing twelve maladaptive variant scales of FFM 
facets with six from conscientiousness (Perfectionism, Fastidiousness, Punctiliousness, 
Workaholism, Doggedness, and Ruminative Deliberation), two from introversion 
(Detached Coldness and Risk Aversion), three from low openness (Constricted, 
Inflexibility, and Dogmatism), and one from neuroticism (Excessive Worry). The 
FFAvA-SF is a 40-item measure assessing ten maladaptive variant scales of FFM facets, 
with four from introversion (Social Dread, Shrinking, Risk Averse, and Joylessness), four 
from neuroticism (Evaluation Apprehension, Despair, Mortified, and Overcome), one 
from low openness (Rigidity), and one from agreeableness (Timorousness).  
Median coefficient alpha for the FFMPD scales at Wave 1 was .71 and ranged 
from .35 (FFOCI Punctiliousness) to .84 (FFBI Dysregulated Anger). Median coefficient 
alpha at Wave 2 was .73 and ranged from .34 (FFOCI Punctiliousness) to .86 (FFBI 
Dissociative Tendencies). 
 RAND-36 Health Status Inventory (HSI). The HSI (Hays & Morales, 2001) is a 
self-report measure of health functioning that includes eight subscales, five of which 
describe physical functioning used in the present study: Physical Functioning (e.g., how 
much participants were limited in activities like exercise, household chores, and 
walking), Role Limitations due to Physical Problems (e.g., was limited in/accomplished 
less due to physical health problems), Pain (e.g., “How much bodily pain have you had 
during the past 4 weeks?”), General Health Perceptions (e.g., “My health is excellent”), 
and Energy/Fatigue (e.g., “Did you feel worn out?”). The lower-order subscales can be 
combined to create composite general, physical, and emotional health scores. The 
physical health composite (PHC) is used in the present study. The measure has validation  
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Table 1. Maladaptive Variants of the Five-Factor Model Facets 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. (-) = scale assesses the opposite pole of the corresponding NEO-PI-R facet.  
FFM Domains                     
and Facets 
Borderline 
(FFBI-SF) 
Obsessive-
Compulsive 
(FFOCI-SF) 
Avoidant 
(FFAvA-SF) 
Neuroticism 
   Anxiousness Anxious 
Uncertainty 
Excessive 
Worry 
Evaluation 
Apprehension 
   Angry Hostility Dysregulated 
Anger 
  
   Depressiveness Despondence  Despair 
   Self-
Consciousness 
Self-
Disturbance 
 Mortified 
   Impulsiveness Behavioral 
Dysregulation 
  
   Vulnerability Affective 
Dysregulation 
& Fragility 
 Overcome 
Extraversion 
   Warmth  Detached 
Coldness (-) 
 
  Gregariousness   Social Dread (-) 
  Assertiveness   Shrinking (-) 
  Activity    
  Excitement- 
Seeking 
 Risk Aversion 
(-) 
Risk Averse (-) 
  Positive 
Emotionality   
  Joylessness (-) 
Conscientiousness 
   Competence  Perfectionism  
   Order  Fastidious  
   Dutifulness  Punctilious  
   Achievement 
Striving 
 Workaholism  
   Self-Discipline  Doggedness  
   Deliberation Rashness (-) Ruminative 
Deliberation 
 
17 
 
support for the assessment of health perceptions (Moorer, Suurmeijer, Foets, & 
Molenaar, 2001). Median coefficient alphas for the HSI scales at Wave 1 were .91 
(Physical Functioning), .89 (Role Limitations Due to Physical Problems), .86 
(Energy/Fatigue), .78 (Pain), and .82 (General Health Perceptions). Median coefficient 
alphas for the HSI scales at Wave 2 were .91 (Physical Functioning), .87 (Role 
Limitations Due to Physical Problems), .87 (Energy/Fatigue), .77 (Pain), and .81 
(General Health Perceptions). Informants completed a 10-item general short version of 
the HSI. Coefficient alpha for the ten items on the informant-HSI was .87 at Wave 1 and 
.85 at Wave 2. 
Health Behavior Checklist (HBCL). Health behaviors were assessed using the 
HBCL (Vickers et al., 1990), a 40-item questionnaire that assesses health behaviors with 
subscales: Wellness Maintenance (e.g., “I exercise to stay healthy”), Traffic Risk (e.g., “I 
speed while driving”), Accident Control (e.g., “I destroy old and unused medicines”), and 
Substance Risk (e.g., “I do not drink alcohol”). Items are rated on a scale from 1 (strongly 
disagree) to 5 (strongly agree). The HBCL has shown longitudinal associations with 
physical health in large samples (Takahashi et al., 2013). Coefficient alphas for the 
HBCL scales at Wave 1 were .74 (Wellness Maintenance), .70 (Accident Control), .74 
(Traffic Risk), and .33 (Substance Risk). Coefficient alphas for the HBCL scales at Wave 
2 were .75 (Wellness Maintenance), .69 (Accident Control), .72 (Traffic Risk), and .31 
(Substance Risk). Informants completed a 10-item short version of the HBCL. 
Coefficient alpha for the informant-HBCL was .59 at Wave 1 and .59 at Wave 2. 
 Insomnia Severity Index (ISI). The ISI (Bastien, Vallières, & Morin, 2001) is a 7-
item questionnaire about insomnia symptoms over the past two weeks. Items are rated 
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from 0 (no distress) to 4 (significant distress). Difficulties with sleep onset latency, wake 
after sleep onset, early waking, and associated distress are assessed. The ISI has extensive 
validation support showing internal consistency, sensitivity, and specificity in the 
identification of insomnia disorder (Morin, Belleville, Belanger, & Ivers, 2011). 
Coefficient alpha for the ISI was .88 at Wave 1 and .89 at Wave 2.  
 Biomarkers. At both waves of the present study, morning fasting blood samples 
(30ml) were collected during a phlebotomy session by research assistants trained in 
phlebotomy in EDTA tubes (Purple Top) from consenting participants between 7:30am-
10:00am via peripheral (primarily antecubital) venipuncture in an independent session 
closely following the in-person assessments. Samples were processed according to 
standard operating procedures before being stored at -80º C (Tuck et al., 2009). 
 Samples were assayed for cytokines at Washington University in St. Louis. IL-6 
and CRP were assayed in duplicate using commercially available enzyme-linked 
immunosorbent assays (IL-6: Quantikine HS Human IL-6 ELISA, R&D Systems, 
Minneapolis, MN, USA; CRP: EIA-3954 High Sensitivity C-Reactive Protein ELISA 
DRG International Inc., USA). Intra- (IL-6: 5%, CRP: 4%) and inter- (IL-6: 14%, CRP: 
13%) assay coefficients of variation were acceptable. Samples producing unreliable 
measures (i.e., intra-assay CVs >20%) of IL-6 (n=38; 4.8%) or CRP (n=22; 2.8%), even 
after being re-assayed in duplicate were excluded leaving 753 and 769 measured data 
points for IL-6 and CRP, respectively, at Wave 1 and 669 and 667 measured data points 
for IL-6 and CRP, respectively, at Wave 2.  
Covariates. At the phlebotomy sessions, several covariates were assessed. Weight 
and height (to calculate body-mass index) and mean arterial pressure were measured in 
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person. Average total sleep, caffeine use, and medications used (prescription, over the 
counter, and supplements) were provided by participants on a questionnaire. Medications 
were put into the following classes: statins, beta blockers, calcium blockers, ACE 
inhibitors, benzodiazepines, hormonal medicines, aspirin, prescription pain medications, 
NSAIDs, steroids, or anti-depressants (e.g., TCA, SSRI, or SNRI). 
2.4 STATISTICAL ANALYSES 
A data-driven analytic plan was developed using correlation and regression to 
examine the associations between FFMPD facets and the indicators of health behaviors, 
health perceptions, and inflammation biomarkers. The incremental validity of FFMPD 
facets over DSM and FFM personality scales was also tested. The plan was preregistered 
(link: http://osf.io/8ystq) and is described in sequence in the Results section.  
The expectation maximization (EM) procedure was used to impute missing data 
for all personality and outcome measures with no more than 20% data missing. EM has 
been shown to create estimates of population parameters that are more accurate than 
substitution of mean values (Enders, 2006). Exceptions for which scoring was not 
appropriate for EM procedure were the self-report HSI (because scoring is based on t-
scores) and self-report ISI (because questions implied “no symptoms” if they were left 
blank). For the self-report HSI, scores were scaled if no more than 2 responses were 
missing. For the self-report ISI, total scores were used.  
To minimize the influence of extreme outliers and non-normality in values of the 
biomarkers, biomarker variables were log transformed and outlier values were winsorized 
to 3 standard deviations before analysis. Biomarkers were correlated with all covariates 
before regression analysis. Significant covariates were included as controls in initial steps 
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of the hierarchical regression analyses. Boxplots of personality variables did not indicate 
problems with significant outliers. Analyses with non-normally distributed self-report 
variables were completed both with and without log transformations of the non-normal 
variables. Results were nearly identical, with no differences in standardized estimates of 
more than .02. Results using non-transformed variables are presented here for ease of 
interpretability.  
Additional exploratory analyses were conducted including age, gender, and race 
as control variables. In the biomarker analyses, medications and other biological 
variables that were significantly correlated with the outcomes were also included as 
control variables. For the CRP analyses, Wave 1 BMI, beta blockers, calcium, steroid, 
anti-depressant, mean arterial pressure, sleep, and Wave 2 BMI, sleep, calcium, ACE 
ARBs, prescription pain medications, steroid, TCA, and beta blockers were included as 
controls. For the IL-6 analyses, Wave 1 BMI, beta blockers, calcium, statins, ACE ARBs, 
prescription pain, antidepressant, mean arterial pressure, sleep, lifetime smoking, current 
smoking, and Wave 2 BMI, sleep, calcium, ACE ARBs, prescription pain, steroid, and 
beta blockers were included as controls. 
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CHAPTER 3.  RESULTS 
Statistical analyses were preregistered (link: http://osf.io/8ystq) and analyses were 
carried out according to the preregistration. Descriptive statistics of study variables are 
provided in Tables 2-5 and correlations of the FFMPD scales with the self-report health 
variables are provided in Tables 6-8, and with the biomarkers in Table 9. Correlations 
significant at p < .001 between 1) the NEO facets and the physical health indicators, 2) 
the DSM personality disorder scales and the physical health indicators, and 3) the 
FFMPD scales and the physical health indicators were carried forward into multiple 
regression models predicting each physical health indicator separately. These models 
consisted of 1) NEO facets of borderline personality disorder predicting the physical 
health indicators, 2) NEO facets of obsessive-compulsive personality disorder predicting 
the physical health indicators, 3) NEO facets of avoidant personality disorder predicting 
the physical health indicators, 4) FFBI facets predicting the physical health indicators, 5) 
FFOCI facets predicting the physical health indicators, and 6) FFAvA facets predicting 
the physical health indicators. Facets significant in those regression models were then 
carried forward to hierarchical regressions. Hierarchical regressions were completed 
including the significant NEO facets in the first step, the corresponding DSM scale in the 
second step (if it was significantly correlated with the outcome), and the significant 
FFMPD facets in the last step. Results from the FFOCI and FFAvA models are presented 
in Tables 10 and 11, respectively. The FFBI facets did not predict the physical health 
indicators at p < .001 in the last step of their respective models, with the exception of 
FFBI Despondence, which predicted HSI Energy/Fatigue over and above other 
significant NEO facets and DSM borderline personality disorder, b = -.22, p < .001.
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Table 2. Descriptive Statistics for Waves 1 and 2 BPD Variables 
 Wave 1 Wave 2 
  Mean SD Skew Kurtosis Mean SD Skew Kurtosis 
FB 
ANX 7.78 3.51 0.88 0.08 7.73 3.73 0.93 0.00 
FB_DA 6.40 3.30 1.65 2.28 6.27 3.16 1.64 2.24 
FB_DP 6.02 2.88 1.91 3.53 6.04 3.09 1.92 3.50 
FB_SD 6.07 2.78 1.66 2.64 6.20 2.93 1.52 1.96 
FB_BD 6.07 2.81 1.64 2.66 6.11 2.75 1.40 1.42 
FB_AD 6.13 2.99 1.79 3.34 5.95 2.86 1.87 3.62 
FB_F 4.96 1.88 3.18 13.78 4.95 1.81 2.70 9.17 
FB_DT 4.77 1.95 3.48 14.67 4.84 2.18 3.29 11.73 
FB_D 6.95 3.15 1.14 0.86 6.95 3.40 1.16 0.63 
FB_M 5.61 2.47 1.90 3.77 5.50 2.35 1.99 4.31 
FB_O 5.80 2.27 1.61 2.88 5.66 2.18 1.77 3.89 
FB_R 6.46 2.97 1.50 2.23 6.30 3.01 1.40 1.32 
MAPP 
BDL 4.13 3.51 1.78 7.00 12.67 3.47 1.46 2.66 
NEON1 13.16 4.88 0.33 0.16 13.33 5.22 0.21 -0.06 
NEON2 11.07 4.54 0.54 0.93 10.97 4.45 0.47 0.59 
NEON3 10.77 5.49 0.73 0.81 10.84 5.69 0.82 0.71 
NEON4 13.11 4.48 0.52 0.57 13.12 4.57 0.49 0.43 
NEON5 14.95 4.25 0.10 -0.19 15.15 4.14 0.04 0.06 
NEON6 9.14 4.01 0.82 1.98 9.21 4.10 0.55 1.03 
NEOO1 16.98 4.57 0.26 -0.26 17.04 4.59 0.21 -0.17 
NEOA1 21.46 4.22 -0.42 0.84 21.32 4.52 -0.56 0.60 
NEOA2 22.47 3.90 -0.13 -0.11 22.59 3.97 -0.34 0.56 
NEOA4 19.38 3.93 -0.17 0.56 19.52 3.98 -0.22 0.21 
NEOC6 19.12 3.86 -0.24 0.16 19.88 3.70 -0.15 0.05 
Note. W1 Ns = 1052-1601; W2 Ns 882-895. FB = FFBI, ANX = Anxious Uncertainty, 
DA = Dysregulated Anger, DP = Despondence, SD = Self-Disturbance, BD = Behavioral 
Dysregulation, AD = Affective Dysregulation, F = Fragility, D = Distrustfulness, M = 
Manipulativeness, O = Oppositional, DT = Dissociative Tendencies, R = Rashness, 
MAPP = Multi-Source Assessment of Personality Pathology, BDL = Borderline, NEO = 
NEO-Personality Inventory-Revised, N1 = Anxiety, N2 = Angry Hostility, N3 = 
Depression, N4 = Self-Consciousness, N5 = Impulsiveness, N6 = Vulnerability, O1 = 
Fantasy, A1 = Trust, A2 = Straightforwardness, A4 = Compliance, C6 = Deliberation.
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Table 3. Descriptive Statistics for Waves 1 and 2 OCPD Variables 
  Wave 1 Wave 2 
  Mean SD Skew Kurtosis Mean SD Skew Kurtosis 
 FO_EW 10.38 4.07 0.27 -0.83 10.33 4.26 0.28 -0.92 
 FO_DC 7.94 3.19 0.70 -0.18 7.88 3.11 0.75 0.05 
 FO_RA 13.66 3.10 -0.22 -0.43 13.62 3.10 -0.21 -0.52 
 FO_C 10.34 3.15 0.13 -0.39 10.21 3.14 0.09 -0.66 
 FO_I 11.14 3.08 0.02 -0.45 10.79 3.03 0.00 -0.47 
 FO_DM 11.27 3.59 0.18 -0.42 11.38 3.65 0.17 -0.49 
 FO_P 15.33 2.54 -0.37 -0.24 15.42 2.60 -0.56 0.39 
 FO_F 12.71 2.93 0.03 -0.42 12.85 3.05 0.05 -0.39 
 FO_PC 15.15 2.25 -0.35 0.35 15.20 2.20 -0.23 0.11 
 FO_W 12.50 2.96 0.00 -0.33 12.53 3.00 -0.08 -0.44 
 FO_DS 13.40 3.13 -0.26 -0.31 13.41 3.14 -0.29 -0.22 
 FO_RD 13.84 2.93 -0.24 -0.19 13.74 2.88 -0.17 -0.37 
 MAPP 
OBC 9.51 4.35 0.46 0.31 17.27 4.28 0.35 -0.12 
 NEON1 13.16 4.88 0.33 0.16 13.33 5.22 0.21 -0.06 
 NEOE1 23.04 4.15 -0.40 0.43 23.07 4.23 -0.31 0.13 
 NEOE5 14.68 4.35 -0.09 -0.07 14.48 4.45 -0.11 -0.27 
 NEOO3 20.17 3.76 0.09 -0.04 20.08 3.76 0.08 -0.12 
 NEOO4 15.80 3.93 -0.03 -0.23 15.52 3.98 0.10 -0.11 
 NEOO6 21.32 4.25 -0.27 0.10 21.24 4.15 -0.26 0.12 
 NEOC1 23.45 3.57 -0.46 1.15 23.58 3.48 -0.33 0.67 
 NEOC2 17.97 4.28 -0.23 0.23 17.93 4.26 -0.14 0.21 
 NEOC3 23.95 3.66 -0.31 0.29 23.81 3.56 -0.35 0.21 
 NEOC4 18.79 4.20 -0.05 0.02 18.68 4.24 -0.07 0.05 
 NEOC5 20.86 4.66 -0.59 0.60 20.69 4.71 -0.59 0.60 
 NEOC6 19.12 3.86 -0.24 0.16 19.88 3.70 -0.15 0.05 
Note. W1 Ns = 1049-1601; W2 Ns 880-895. FO = FFOCI, EW = Excessive Worry, DC = 
Detached Coldness, RA = Risk Aversion, C = Constricted, I = Inflexibility, DM = 
Dogmatism, P = Perfectionism, F = Fastidiousness, PC = Punctiliousness, W = 
Workaholism, DS = Doggedness, RD = Ruminative Deliberation, MAPP = Multi-Source 
Assessment of Personality Pathology, OBC = Obsessive-Compulsive, NEO = NEO-
Personality Inventory-Revised, N1 = Anxiety, E1 = Warmth, E5 = Excitement-Seeking, 
O3 = Feelings, O4 = Actions, O6 = Values,  C1 = Competence, C2 = Order, C3 = 
Dutifulness, C4 = Achievement-Striving, C5 = Self-Discipline, C6 = Deliberation.
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Table 4. Descriptive Statistics for Waves 1 and 2 AVPD Variables 
  Wave 1 Wave 2 
Scales Mean SD Skew 
Kurto
sis Mean SD Skew Kurtosis 
 FAVA_EA 6.83 2.92 1.15 1.09 6.70 3.10 1.38 1.52 
 FAVA_D 7.03 3.10 1.26 1.43 7.03 3.23 1.19 0.92 
 FAVA_M 6.80 3.08 1.51 2.59 6.52 2.95 1.58 2.60 
 FAVA_O 8.03 2.90 0.73 0.45 7.85 2.81 0.64 0.10 
 FAVA_SD 9.63 3.60 0.43 -0.45 9.91 3.61 0.43 -0.53 
 FAVA_S 9.86 3.16 0.39 -0.16 9.91 3.27 0.33 -0.24 
 FAVA_RA 14.62 3.49 -0.38 -0.57 14.76 3.51 -0.51 -0.36 
 FAVA_J 8.27 3.17 0.70 0.12 8.35 3.26 0.68 0.04 
 FAVA_R 11.10 2.57 0.29 -0.06 11.20 2.59 0.25 -0.28 
 FAVA_T 15.90 2.77 -0.47 -0.24 16.27 2.75 -0.59 -0.13 
 MAPP AVD 4.56 4.00 1.46 3.13 11.42 3.86 1.25 1.68 
 NEON1 13.16 4.88 0.33 0.16 13.33 5.22 0.21 -0.06 
 NEON3 10.77 5.49 0.73 0.81 10.84 5.69 0.82 0.71 
 NEON4 13.11 4.48 0.52 0.57 13.12 4.57 0.49 0.43 
 NEON6 9.14 4.01 0.82 1.98 9.21 4.10 0.55 1.03 
 NEOE2 16.40 5.05 -0.30 -0.11 16.18 5.07 -0.24 -0.13 
 NEOE3 16.66 4.56 -0.15 -0.10 16.23 4.71 -0.10 0.01 
 NEOE5 14.68 4.35 -0.09 -0.07 14.48 4.45 -0.11 -0.27 
 NEOE6 20.05 4.88 -0.36 0.40 19.99 5.04 -0.35 -0.02 
 NEOO4 15.80 3.93 -0.03 -0.23 15.52 3.98 0.10 -0.11 
 NEOA5 20.03 4.15 -0.19 0.22 20.23 4.08 -0.28 0.28 
Note. W1 Ns = 1049-1601; W2 Ns 882-895. FAVA = FFAvA, EA = Evaluation 
Apprehension, D = Despair, M = Mortified, O = Overcome, SD = Social Dread, S = 
Shrinking, Risk, RA = Risk Averse, J = Joylessness, R = Rigidity, T = Timorousness, 
MAPP = Multi-Source Assessment of Personality Pathology, AVD = Avoidant, NEO = 
NEO-Personality Inventory-Revised, N1 = Anxiety, N3 = Depression, N4 = Self-
Consciousness, N6 = Vulnerability, E2 = Gregariousness, E3 = Assertiveness, E5 = 
Excitement-Seeking, E6 = Positive Emotions, O4 = Actions, A5 = Modesty.
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Table 5. Descriptive Statistics for Waves 1 and 2 Physical Health Indicator Variables 
  Wave 1 Wave 2 
Scale Mean SD Skew Kurtosis Mean SD Skew Kurtosis 
ISI 5.87 4.91 1.11 1.11 6.09 5.02 1.03 0.90 
WELLNESS 36.57 6.06 -0.45 0.41 36.42 6.16 -0.51 0.78 
ACCIDENT 20.75 3.93 -0.31 0.44 20.66 3.86 -0.26 0.38 
TRAFFIC 26.33 4.34 -0.15 -0.27 26.59 4.20 -0.26 -0.07 
SUBSTANCE 11.50 2.32 -0.49 0.47 11.61 2.21 -0.50 0.51 
HBCL GHP 60.69 8.05 -0.44 0.10 60.58 8.24 -0.48 0.44 
HSI PF 464.68 94.90 -0.99 -0.06 459.84 94.97 -0.95 -0.13 
HSI RLP 243.83 65.68 -1.11 -0.40 238.04 67.17 -0.94 -0.72 
HSI PA 110.58 38.90 -0.68 -0.29 109.35 38.05 -0.54 -0.53 
HSI GHP 303.72 79.43 -0.45 -0.46 317.12 82.58 -0.82 0.03 
HSI EF 191.90 76.68 -0.18 -0.70 191.70 77.47 -0.15 -0.76 
HSI PHC 59.57 9.81 -0.90 -0.03 54.45 5.89 -0.35 -0.33 
I-HBCL 38.11 5.04 -0.30 0.07 38.47 5.02 -0.30 -0.29 
I-HSI 2.10 0.69 1.33 1.74 2.06 0.65 1.35 1.73 
IL-6 2.65 5.72 11.91 161.29 3.44 9.67 15.31 295.12 
CRP 5.83 12.02 6.37 51.63 3.74 6.63 5.24 37.33 
Note. Ns for W1 self-report questionnaires 1039-1053, W1 biomarkers 650-769, and W1 
informant-reports 741-845. Ns for W2 self-report questionnaires 633-906, W2 
biomarkers 666-669, and W2 informant-reports 433-562. ISI = Insomnia Severity Index, 
HBCL = Health Behavior Checklist, HSI = Health Status Inventory, GHP = General 
Health Perceptions, PF = Physical Functioning, RLP = Role Limitations due to Physical 
Problems, PA = Pain, EF = Energy/Fatigue, PHC = Physical Health Composite, I = 
informant.
  
 
Table 6. Correlations Among Wave 1 FFBI and Wave 2 Self- and Informant-Report Physical Health Indicators 
 Scale 
W2 
ISI 
W2 
IHB 
W2 
IHSI 
W2 
PF 
W2 
RLP 
W2 
PA 
W2 
HSI 
G 
W2 
EF 
W2 
PHC 
W2 
WEL 
W2 
ACC 
W2 
TRF 
W2 
SUB 
W2 
HB G 
W1 FB_ANX .31 .03 .22 -.19 -.18 -.17 -.28 -.34 -.22 -.08 -.12 .05 .01 -.11 
W1 FB_DA .24 -.07 .22 -.15 -.16 -.15 -.22 -.24 -.17 -.07 -.12 -.07 -.09 -.12 
W1 FB_DP .31 -.07 .25 -.23 -.19 -.21 -.34 -.40 -.27 -.19 -.18 -.02 -.06 -.23 
W1 FB_SD .32 -.12 .25 -.26 -.19 -.22 -.30 -.39 -.24 -.19 -.18 -.04 -.06 -.24 
W1 FB_BD .25 -.16 .16 -.18 -.14 -.15 -.25 -.27 -.20 -.16 -.15 -.15 -.10 -.21 
W1 FB_AD .33 -.09 .24 -.26 -.22 -.23 -.34 -.37 -.29 -.13 -.17 -.06 -.10 -.19 
W1 FB_F .27 -.10 .26 -.22 -.17 -.17 -.27 -.29 -.23 -.15 -.12 .00 -.12 -.22 
W1 FB_DT .22 -.16 .19 -.20 -.13 -.15 -.20 -.23 -.18 -.13 -.12 -.04 -.15 -.18 
W1 FB_D .30 -.07 .17 -.23 -.15 -.19 -.27 -.33 -.27 -.19 -.13 -.01 -.04 -.23 
W1 FB_M .10 -.17 .01 -.04 -.03 -.02 -.11 -.08 -.07 -.12 -.09 -.19 -.08 -.14 
W1 FB_O .19 -.10 .12 -.14 -.10 -.11 -.20 -.22 -.17 -.12 -.11 -.09 -.05 -.17 
W1 FB_R .23 -.10 .18 -.15 -.14 -.16 -.24 -.23 -.21 -.16 -.18 -.16 -.09 -.21 
Note. Bold = p < .001. W1 = Wave 1, W2 = Wave 2, FB = FFBI, ANX = Anxious Uncertainty, DA = Dysregulated Anger, DP = 
Despondence, SD = Self-Disturbance, BD = Behavioral Dysregulation, AD = Affective Dysregulation, F = Fragility, D = 
Distrustfulness, M = Manipulativeness, O = Oppositional, DT = Dissociative Tendencies, R = Rashness, ISI = Insomnia Severity 
Index, HB = Health Behavior Checklist, HSI = Health Status Inventory, GHP = General Health Perceptions, PF = Physical 
Functioning, RLP = Role Limitations due to Physical Problems, PA = Pain, EF = Energy/Fatigue, PHC = Physical Health Composite, 
I = informant, WEL = HBCL Wellness, ACC = HBCL Accident, TRF = HBCL Traffic Risk, SUB = HBCL Substance Risk, G = 
General Health Perceptions.
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Table 7. Correlations Among Wave 1 FFOCI Scales and Wave 2 Self- and Informant-Report Physical Health Indicators 
 Scale 
W2 
ISI 
W2 
IHB 
W2 
IHSI 
W2 
PF 
W2 
RLP 
W2 
PA 
W2 
HSI 
G 
W2 
EF 
W2 
PHC 
W2 
WEL 
W2 
ACC 
W2 
TRF 
W2 
SUB 
W2 
HB G 
W1 FO_EW .32 .04 .14 -.16 -.15 -.14 -.24 -.32 -.20 -.07 -.12 .09 -.01 -.08 
W1 FO_DC .14 -.10 .12 -.13 -.06 -.11 -.24 -.21 -.23 -.24 -.24 -.08 .03 -.26 
W1 FO_RA .09 .07 .04 -.21 -.09 -.04 -.12 -.14 -.14 -.13 -.01 .30 .12 -.14 
W1 FO_C -.01 -.09 -.06 -.08 .01 .00 -.13 -.06 -.10 -.22 -.12 -.06 .04 -.23 
W1 FO_I .05 .06 .04 -.14 -.01 -.02 -.16 -.14 -.17 -.20 -.13 .10 .08 -.21 
W1 FO_DM .00 .06 .02 -.14 -.03 -.04 -.07 -.04 -.12 -.09 .15 .09 .07 -.12 
W1 FO_P -.04 .03 -.03 .04 .02 -.03 .10 .08 .08 .07 .18 .09 .09 .10 
W1 FO_F -.01 .02 -.03 .03 .05 .01 .06 .10 .07 .11 .16 .08 .04 .11 
W1 FO_PC -.04 .12 -.06 .00 .02 .02 .09 .07 .07 .10 .21 .17 .10 .11 
W1 FO_W -.06 .06 -.15 .03 .05 .02 .09 .12 .08 .06 .18 .00 .04 .05 
W1 FO_DS -.04 .11 -.12 .10 .08 .05 .13 .17 .10 .13 .20 .07 .06 .14 
W1 FO_RD -.05 .10 -.05 .01 .06 .07 .07 .07 .04 .09 .19 .25 .10 .10 
Note. Bold = p < .001. W1 = Wave 1, W2 = Wave 2, FO = FFOCI, EW = Excessive Worry, DC = Detached Coldness, RA = Risk 
Aversion, C = Constricted, I = Inflexibility, DM = Dogmatism, P = Perfectionism, F = Fastidiousness, PC = Punctiliousness, W = 
Workaholism, DS = Doggedness, RD = Ruminative Deliberation, ISI = Insomnia Severity Index, HB = Health Behavior Checklist, 
HSI = Health Status Inventory, PF = Physical Functioning, RLP = Role Limitations due to Physical Problems, PA = Pain, EF = 
Energy/Fatigue, PHC = Physical Health Composite, I = informant, WEL = HBCL Wellness, ACC = HBCL Accident, TRF = HBCL 
Traffic Risk, SUB = HBCL Substance Risk, G = General Health Perceptions.
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Table 8. Correlations Among Wave 1 FFAvA Scales and Wave 2 Self- and Informant-Report Physical Health Indicators 
Scale 
W2 
ISI 
W2 
IHB 
W2 
IHSI 
W2 
PF 
W2 
RLP 
W2 
PA 
W2 
HSI 
G 
W2 
EF 
W2 
PHC 
W2 
WEL 
W2 
ACC 
W2 
TRF 
W2 
SUB 
W2 
HB G 
W1 FAVA_EA .24 .01 .09 -.21 -.11 -.18 -.26 -.31 -.26 -.16 -.15 -.01 -.04 -.19 
W1 FAVA_D .36 -.09 .23 -.31 -.19 -.27 -.38 -.44 -.35 -.25 -.20 .00 -.05 -.30 
W1 FAVA_M .20 .01 .09 -.23 -.10 -.15 -.25 -.28 -.24 -.20 -.17 -.01 -.02 -.22 
W1 FAVA_O .24 -.06 .22 -.23 -.11 -.16 -.27 -.24 -.25 -.13 -.20 .03 -.03 -.17 
W1 FAVA_SD .14 .03 .07 -.10 -.07 -.09 -.20 -.25 -.17 -.21 -.24 .00 .07 -.22 
W1 FAVA_S .13 .02 .10 -.15 -.09 -.06 -.18 -.20 -.14 -.20 -.20 .06 .02 -.20 
W1 FAVA_RA .06 .19 .04 -.17 -.08 -.02 -.15 -.12 -.11 -.09 -.06 .40 .12 -.07 
W1 FAVA_J .27 -.10 .33 -.28 -.18 -.19 -.39 -.41 -.32 -.26 -.22 .02 .00 -.31 
W1 FAVA_R .05 .09 .02 -.11 -.03 .03 -.16 -.12 -.12 -.14 -.13 .09 .10 -.13 
W1 FAVA_T -.01 .08 .00 .05 -.02 .05 .08 -.06 .11 .06 .01 .10 .06 .08 
Note. Bold = p < .001. W1 = Wave 1, W2 = Wave 2, FA = FFAvA, EA = Evaluation Apprehension, D = Despair, M = Mortified, O = 
Overcome, SD = Social Dread, S = Shrinking, Risk, RA = Risk Averse, J = Joylessness, R = Rigidity, T = Timorousness, ISI = 
Insomnia Severity Index, HB = Health Behavior Checklist, HSI = Health Status Inventory, PF = Physical Functioning, RLP = Role 
Limitations due to Physical Problems, PA = Pain, EF = Energy/Fatigue, PHC = Physical Health Composite, I = informant, WEL = 
HBCL Wellness, ACC = HBCL Accident, TRF = HBCL Traffic Risk, SUB = HBCL Substance Risk, G = General Health Perceptions.
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Table 9. Correlations Among Wave 1 FFMPD Scales and Wave 2 Biomarkers 
FFBI Scale 
W2 
CRP 
W2 
IL-6 FFOCI Scale 
W2 
CRP 
W2 
IL-6 FAVA Scale 
W2 
CRP 
W2 
IL-6 
W1 FB_ANX .01 .07 W1 FO_EW .02 .01 W1 FAVA_EA -.03 -.03 
W1 FB_DA .00 .05 W1 FO_DC -.01 -.01 W1 FAVA_D .00 .05 
W1 FB_DP .01 .06 W1 FO_RA .09 .06 W1 FAVA_M .00 -.01 
W1 FB_SD .03 .11 W1 FO_C -.03 -.01 W1 FAVA_O -.01 .03 
W1 FB_BD .01 .08 W1 FO_I .01 .03 W1 FAVA_SD -.03 -.02 
W1 FB_AD .03 .08 W1 FO_DM .11 .04 W1 FAVA_S .01 .02 
W1 FB_F .04 .12 W1 FO_P .02 -.04 W1 FAVA_RA .09 .04 
W1 FB_DT .01 .13 W1 FO_F .03 -.06 W1 FAVA_J .01 .08 
W1 FB_D .04 .06 W1 FO_PC .09 .02 W1 FAVA_R -.03 -.03 
W1 FB_M -.02 .06 W1 FO_W .06 .03 W1 FAVA_T -.03 -.03 
W1 FB_O -.04 .02 W1 FO_DS .06 .01       
W1 FB_R -.04 .06 W1 FO_RD .08 .06       
Note. W1 = Wave 1, W2 = Wave 2, FB = FFBI, ANX = Anxious Uncertainty, DA = Dysregulated Anger, DP = Despondence, SD = 
Self-Disturbance, BD = Behavioral Dysregulation, AD = Affective Dysregulation, F = Fragility, D = Distrustfulness, M = 
Manipulativeness, O = Oppositional, DT = Dissociative Tendencies, R = Rashness, FO = FFOCI, EW = Excessive Worry, DC = 
Detached Coldness, RA = Risk Aversion, C = Constricted, I = Inflexibility, DM = Dogmatism, P = Perfectionism, F = Fastidiousness, 
PC = Punctiliousness, W = Workaholism, DS = Doggedness, RD = Ruminative Deliberation, FA = FFAvA, EA = Evaluation 
Apprehension, D = Despair, M = Mortified, O = Overcome, SD = Social Dread, S = Shrinking, Risk, RA = Risk Averse, J = 
Joylessness, R = Rigidity, T = Timorousness, ISI = Insomnia Severity Index, HB = Health Behavior Checklist, HSI = Health Status 
Inventory, PF = Physical Functioning, RLP = Role Limitations due to Physical Problems, PA = Pain, EF = Energy/Fatigue, PHC = 
Physical Health Composite, I = informant, WEL = HBCL Wellness, ACC = HBCL Accident, TRF = HBCL Traffic Risk, SUB = 
HBCL Substance Risk, G = General Health Perceptions. Correlations greater than or equal to .10 significant at p < .01.
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Table 10. Five-Factor Obsessive-Compulsive Inventory Scales’ Incremental Validity over NEO and MAPP 
 Predicting Physical Indicators 
Wave 2 
Outcome 
Last step 
Adj R2 
Last step D 
R2  Wave 1 Predictor b 
95% CI 
lower 
95% CI 
upper b 
ISI .12 .01 NEO N1 0.19 0.10 0.28 .19 
      FFOCI EW 0.20 0.09 0.31 .17 
I-HSI .02 .02 FFOCI W -0.03 -0.05 -0.01 -.15 
WELLNESS .02 .02 FFOCI DS 0.26 0.12 0.39 .13 
ACCIDENT .14 .03 NEO E1 0.20 0.12 0.29 .22 
      NEO C6 0.16 0.09 0.23 .16 
      FFOCI DM 0.18 0.11 0.25 .16 
TRAFFIC .14 .05 NEO C6 0.20 0.11 0.29 .18 
      FFOCI RA 0.32 0.22 0.42 .23 
HBC GHP .15 .04 NEO C3 0.66 0.50 0.82 .29 
      FFOCI DC -0.53 -0.70 -0.37 -.21 
HSI PA .02 .02 FFOCI EW -1.32 -1.97 -0.66 -.14 
HSI GHP .15 .03 NEO N1 -5.11 -6.87 -3.35 -.32 
      FFOCI DC -4.43 -6.36 -2.50 -.18 
HSI PHC .15 .02 NEO N1 -0.32 -0.43 -0.20 -.27 
      NEO O6 0.23 0.13 0.32 .17 
      FFOCI DC -0.26 -0.39 -0.13 -.15 
Note. All last steps and predictors significant at p < .001. ISI = insomnia severity index, I = informant,  
HSI = health status inventory, HBC = health behavior checklist, GHP = general health perceptions,  
PA = pain, PHC = physical health composite, N1 = Anxiety, E1 = Warmth, O6 = Values, C3 = Dutifulness, 
C6 = Deliberation, EW = Excessive Worry, W = Workaholism, DS = Doggedness, DM = Dogmatism,  
DC = Detached Coldness.   
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Table 11. Five-Factor Avoidant Inventory Scales’ Incremental Validity over NEO and MAPP  
Predicting Physical Health Indicators 
Wave 2 
Outcome 
Last step 
Adj R2 
Last step 
D R2 Wave 1 Predictor  b 
95% CI 
lower 
95% CI 
upper b 
ISI .15 .02 NEO N3 0.19 0.11 0.27 .21 
      FAVA D 0.33 0.19 0.47 .21 
I-HBC .03 .04 FAVA RA 0.27 0.14 0.40 .19 
I-HSI .11 .11 FAVA J 0.06 0.05 0.08 .33 
ACCIDENT .09 .02 NEO N6 -0.21 -0.28 -0.14 -.22 
      FAVA SD -0.18 -0.26 -0.10 -.17 
TRAFFIC .15 .13 FAVA RA 0.49 0.40 0.57 .41 
HBC GHP .11 .05 FAVA J -0.49 -0.70 -0.28 -.19 
HSI PF .09 .06 FAVA D -8.30 -10.67 -5.94 -.28 
HSI PA .07 .07 FAVA D -3.28 -4.14 -2.42 -.27 
HSI GHP .18 .06 FAVA D -5.46 -8.10 -2.82 -.20 
      FAVA J -5.36 -8.24 -2.49 -.21 
HSI EF .25 .06 NEO N3 -2.59 -3.89 -1.29 -.19 
      FAVA D -4.58 -6.93 -2.22 -.18 
      FAVA J -4.64 -6.59 -2.69 -.19 
HSI PHC .14 .10 FAVA D -0.45 -0.62 -0.28 -.23 
      FAVA J -0.32 -0.48 -0.17 -.18 
Note. All last steps and predictors significant at p < .001. ISI = insomnia severity index, I = informant,  
HBC = health behavior checklist, HSI = health status inventory, GHP = general health perceptions,  
PF = physical functioning, PA = pain, EF = energy/fatigue, PHC = physical health composite, N3 = 
Depression, N6 = Vulnerability, D = Despair, RA = Risk Averse, J = Joylessness, SD = Social Dread.  
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 To further examine these results, the physical health indicator variables at Wave 
1 were added to the models in a new first step. In these models, only FFAvA Joylessness, 
FFAvA Risk Aversion, and FFAvA Despair remained significant individual predictors in 
the last steps of their respective models (predicting informant-rated health status 
inventory; b = .13, Traffic Risk; b = .12, and HSI Pain; b = -.12, respectively).  
 The previously described preregistered regression models included several facets 
in each step. The large number of predictors likely reduced the power of the analyses (J.  
Cohen, Cohen, West, & Aiken, 2003). Further, there was multicollinearity among the 
predictors (e.g., the FFBI scales’ median intercorrelation was r = .51), which can affect 
the estimates of individual predictors in the models. In some preregistered analyses, 
single FFMPD scales were tested against multiple NEO scales, and most models included 
NEO and FFMPD facets that assess different specific components of personality. To 
avoid these issues and test incremental validity of the FFMPD scales in a more 
straightforward way, exploratory regression analyses were completed examining the 
predictive validity of the FFMPD facets one by one. These analyses also included 
covariates: the physical health indicators at Wave 1 and demographic variables that were 
significantly correlated with the Wave 2 physical health indicators (e.g., age, gender, 
race). Controlling for the physical health indicator variables at Wave 1 represents a tough 
test of the personality variables, as significant results would now indicate that the 
personality variables predict change in the physical health indicator variables across time. 
The significant predictors in these models are presented in Tables 12 (FFBI) and 13 
(FFAvA). None of the FFOCI facets were significantly predictive of change in the 
physical health indicators in these models. 
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Table 12. Five-Factor Borderline Scales Predicting Physical Health Indicators Over 
Covariates  
Note. All significant at p < .001. ISI = Insomnia Severity Index, I-HSI = informant-
reported heath status inventory, HBC = health behavior checklist, GHP = general health 
perceptions, HSI = health status inventory, PF = physical functioning, PA = pain, EF = 
energy/fatigue, PHC = physical health composite, CRP = c-reactive protein.
Wave 2 
Outcome   Wave 1 Predictor Scale b 
95% 
lower 
95% 
upper b 
ISI FFBI Anxious Uncertainty 0.16 0.09 0.24 .11 
 FFBI Dysregulated Anger 0.14 0.06 0.22 .09 
 FFBI Despondence 0.19 0.10 0.29 .11 
 FFBI Self-Disturbance 0.20 0.10 0.30 .11 
 FFBI Behavioral Dysregulation 0.19 0.09 0.28 .10 
 FFBI Dissociative Tendencies 0.30 0.16 0.45 .11 
 FFBI Distrustfulness 0.20 0.11 0.28 .12 
 FFBI Rashness 0.20 0.11 0.29 .12 
WELLNESS FFBI Despondence -0.24 -0.35 -0.13 -.11 
 FFBI Self-Disturbance -0.23 -0.35 -0.12 -.10 
 FFBI Fragility -0.40 -0.58 -0.22 -.11 
 FFBI Distrustfulness -0.17 -0.28 -0.07 -.09 
 FFBI Rashness -0.19 -0.30 -0.08 -.09 
HBC GHP FFBI Despondence -0.32 -0.46 -0.19 -.11 
 FFBI Self-Disturbance -0.33 -0.47 -0.19 -.11 
 FFBI Behavioral Dysregulation -0.29 -0.43 -0.15 -.09 
 FFBI Fragility -0.57 -0.79 -0.35 -.12 
 FFBI Dissociative Tendencies -0.45 -0.66 -0.23 -.09 
 FFBI Distrustfulness -0.24 -0.36 -0.11 -.09 
 FFBI Rashness -0.29 -0.42 -0.15 -.10 
HSI PF FFBI Self-Disturbance -3.13 -4.72 -1.54 -.09 
HSI PA FFBI Despondence -1.72 -2.55 -0.89 -.13 
HSI GHP FFBI Despondence -2.66 -4.16 -1.15 -.09 
HSI EF FFBI Despondence -2.74 -4.28 -1.20 -.10 
 FFBI Self-Disturbance -3.22 -4.81 -1.62 -.11 
 FFBI Behavioral Dysregulation -2.65 -4.17 -1.14 -.09 
 FFBI Distrustfulness -2.44 -3.80 -1.08 -.10 
PHC FFBI Despondence -0.24 -0.36 -0.12 -.12 
 FFBI Distrustfulness -0.20 -0.31 -0.09 -.10 
 FFBI Rashness -0.21 -0.32 -0.09 -.10 
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Table 13. Five-Factor Avoidant Scales Predicting Physical Health Indicators Over 
Covariates  
Note. All significant at p < .001. ISI = Insomnia Severity Index, I-HSI = informant-
reported heath status inventory, HBC = health behavior checklist, GHP = general health 
perceptions, HSI = health status inventory, PF = physical functioning, PA = pain, EF = 
energy/fatigue, PHC = physical health composite, CRP = c-reactive protein. 
Wave 2 
Outcome  Wave 1 Predictor Scale b 
95% 
lower 
95% 
upper b 
ISI FAVA Despair 0.21 0.13 0.30 .13 
 FAVA Shrinking 0.13 0.06 0.21 .09 
 FAVA Joylessness 0.14 0.07 0.22 .09 
I-HSI FAVA Joylessness 0.03 0.01 0.04 .13 
WELLNESS FAVA Despair -0.18 -0.29 -0.08 -.09 
 FAVA Shrinking -0.18 -0.28 -0.08 -.09 
ACCIDENT FAVA Social Dread -0.12 -0.17 -0.06 -.11 
 FAVA Risk Averse 0.11 0.05 0.18 .09 
HBC GHP FAVA Evaluation Apprehension -0.22 -0.35 -0.09 -.08 
 FAVA Despair -0.26 -0.38 -0.13 -.10 
 FAVA Mortified -0.23 -0.35 -0.10 -.08 
 FAVA Overcome -0.23 -0.36 -0.10 -.08 
HSI PF FAVA Evaluation Apprehension -2.65 -4.10 -1.21 -.08 
 FAVA Despair -2.68 -4.09 -1.28 -.09 
 FAVA Mortified -3.14 -4.53 -1.75 -.10 
 FAVA Overcome -2.47 -3.93 -1.00 -.08 
 FAVA Joylessness -2.80 -4.15 -1.45 -.10 
HSI GHP FAVA Despair -2.46 -3.87 -1.05 -.09 
 FAVA Joylessness -2.42 -3.74 -1.09 -.10 
HSI PA FAVA Despair -1.55 -2.31 -0.78 -.13 
HSI EF FAVA Evaluation Apprehension -2.88 -4.26 -1.50 -.11 
 FAVA Despair -3.39 -4.80 -1.99 -.14 
 FAVA Social Dread -2.10 -3.20 -1.00 -.10 
 FAVA Joylessness -3.14 -4.47 -1.82 -.13 
PHC FAVA Evaluation Apprehension -0.29 -0.40 -0.18 -.14 
 FAVA Despair -0.28 -0.39 -0.16 -.14 
 FAVA Mortified -0.23 -0.35 -0.12 -.12 
 FAVA Overcome -0.25 -0.37 -0.13 -.12 
 FAVA Social Dread -0.17 -0.26 -0.07 -.10 
 FAVA Joylessness -0.26 -0.36 -0.15 -.14 
CRP  FAVA Despair -0.03 -0.04 -0.01 -.16 
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In a further set of exploratory analyses, incremental validity of the FFMPD scales 
over their direct corresponding NEO-PI-R facets was tested. For example, in one model 
NEO-PI-R Anxiety was included as a control in an initial step before FFAvA Evaluation 
Apprehension (a maladaptive variant of the facet of anxiousness) was included in the 
next step. In these analyses, 46 of 61 FFMPD facets remained significant predictors of 
the variance in the outcomes at p < .05. Twenty-nine were still significant at p < .01. 
Fifteen had incremental validity at p < .001. The 15 FFMPD facets and their directly 
corresponding NEO-PI-R facets over which they showed incremental validity at p < .001 
are presented in Table 14. 
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Table 14. FFMPD Incremental Validity Over Covariates and Corresponding NEO Facets 
Wave 2 Outcome 
Wave 1 
Predictor  b p  Adj R2 DR2 DF df 
ISI NEO O1 .00 .970 .48 .011 17.22 807 
  FFBI DT .11 .000         
ISI NEO C6 .00 .926 .48 .010 16.06 807 
  FFBI R .12 .000         
Wellness NEO N4 -.01 .610 .51 .007 10.95 776 
  FFBI SD -.09 .001         
Wellness NEO N6 -.02 .486 .51 .008 12.55 776 
  FFBI F -.10 .000         
HSI G NEO N4 -.01 .680 .59 .008 15.37 775 
  FFBI SD -.10 .000         
HSI G NEO N5 .00 .905 .59 .007 14.23 775 
  FFBI BD -.10 .000         
HSI G NEO N6 -.01 .638 .60 .010 19.26 775 
  FFBI F -.11 .000         
HSI G NEO O1 .00 .920 .59 .009 16.63 775 
  FFBI DT -.09 .000         
HSI G NEO C6 .03 .271 .59 .006 11.50 775 
  FFBI R -.09 .001         
PF NEO E6 -.03 .352 .63 .007 12.87 689 
  FAVA J -.12 .000         
PF NEO E6 -.04 .248 .63 .006 12.49 708 
  FAVA J -.12 .000         
EF NEO N3 -.03 .355 .54 .007 11.11 708 
  FAVA D -.12 .001         
EF NEO E6 -.03 .394 .54 .011 16.38 708 
  FAVA J -.15 .000         
PHC NEO N1 -.05 .109 .46 .011 13.64 686 
  FAVA EA -.12 .000         
CRP NEO N3 .03 .546 .44 .018 12.00 352 
  FAVA D -.18 .001         
Note. ISI = Insomnia Severity Index, Wellness = Wellness Maintenance, HSI G = Health 
Status Inventory General Health Perceptions, PF = Physical Functioning, EF = 
Energy/Fatigue, PHC = Physical Health Composite, CRP = C-reactive protein, NEO = 
NEO-PI-R, FB = Five-Factor Borderline Inventory, FAVA = Five-Factor Avoidant 
Inventory, O1 = Fantasy, C6 = Deliberation, N1 = Anxiety, N3 = Depression, N4 = Self-
Consciousness, N5 = Impulsiveness, N6 = Vulnerability, E6 = Positive Emotions, DT = 
Dissociative Tendencies, R = Rashness, SD = Self-Disturbance, F = Fragility, BD = 
Behavioral Dysregulation, J = Joylessness, D = Despair, EA = Evaluation Apprehension.  
 37 
 
CHAPTER 4.  DISCUSSION 
Personality has well-documented effects on important outcomes in life (Ozer & 
Benet-Martinez, 2006; Roberts et al., 2007). In particular, research indicates that 
personality is associated with physical health (T. W. Smith et al., 2015; Strickhouser et 
al., 2017). However, less research has examined how maladaptive personality traits relate 
to physical health. The present study provides initial work examining the criterion 
validity of facets from the FFMPD—a dimensional model of personality disorder with a 
large and growing body of research support—for predicting physical health indicators.  
 Results from the present study indicate that maladaptive FFMPD facets have 
significant associations with health behaviors and health perceptions across time in older 
adults. FFMPD facets were correlated with biomarkers of inflammation across time, but 
did not provide incremental validity about biomarkers above covariates. Findings of the 
longitudinal and incremental associations of the FFMPD with health behaviors and health 
perceptions were particularly strong, as the associations remained in many instances 
while controlling for demographic control variables, outcome variables at Wave 1, as 
well as normal range personality and DSM personality disorder. These incremental 
analyses indicate FFMPD scales predict changes in physical health behavior and 
perceptions across time in older adults.  
 Findings from the present study support prior research results and theoretical 
suggestions that a dimensional model of personality disorder improves the traditional 
categorical model of personality disorder. The present findings suggest that maladaptive 
variants of the personality traits from the FFM are important to describing problems in 
physical health functioning. For example, while higher levels of the adaptive FFM scale 
 38 
 
NEO-PI-R Anxiety predict general perceptions of physical health, higher levels of a 
maladaptive variant of anxiousness, FFAvA Evaluation Apprehension, predict even more 
variance in general perceptions of physical health (Table 14). Likewise, while higher 
levels of the adaptive FFM scale NEO-PI-R Fantasy predict insomnia symptoms, higher 
levels of its maladaptive variant, FFBI Dissociative Tendencies, predict even more 
variance in insomnia symptoms (Table 14). Results signal that the maladaptive variants 
of FFM traits have implications for physical health behaviors and perceptions because 
they predict outcomes over and above the adaptive variants of the same traits.  
The DSM personality disorder scales correlated with the physical health 
outcomes, but regression analyses indicted that the DSM personality disorders did not 
predict unique variance in the physical health outcomes that the FFMPD model did not 
predict. There are several reasons why the DSM personality disorders may not be as 
successful for predicting physical health outcomes as the FFMPD, which relate to some 
of the core problems of the DSM approach to the classification and assessment of 
personality disorders. First, they suffer from inadequate coverage of the full range of 
maladaptive personality functioning. The FFMPD provides a more comprehensive model 
of personality functioning because it traces its roots to the Big Five, a trait model derived 
from factor analysis of virtually every trait term within the English and other languages 
(De Raad & Mlacic, 2017). To the extent that the Big Five includes every maladaptive 
trait term, it naturally follows that the FFM, aligned with the Big Five, accounts for 
virtually every maladaptive personality trait (Widiger & Crego, 2019). Second, the DSM 
system may be less adequate for predicting health outcomes because of the heterogeneity 
within the DSM personality disorder criteria. Individuals may be diagnosed with the 
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same personality disorder, for example borderline personality disorder, with almost 
entirely different symptoms. Thus, a score for borderline personality disorder is not 
composed of specific content—as the FFMPD facets are—and this may interfere with 
criterion validity. Finally, DSM personality disorder assessments often assess each 
symptom with only one item. The FFMPD framework conceptualizes each trait (i.e., 
symptom) as a homogeneous construct that requires more than one item to assess. This 
focus on construct homogeneity likely improves criterion validity because the FFMPD 
scales are more comprehensive, and therefore more reliable, and a more reliable measure 
is a more powerful predictor (G. T. Smith, McCarthy, & Zapolski, 2009). This is in part 
because it will not suffer as much from attenuation. The improvements in criterion 
validity for physical health indicators in the present study likely reflect the improvements 
of a dimensional model of personality disorder over a categorical one, as a whole.  
Several specific findings emerge from the present study as most notable. First, the 
FFAvA Despair scale predicted many outcomes including showing incremental validity 
over the NEO and DSM personality scales. Correlations between Wave 1 Despair and 
Wave 2 general health perceptions, energy/fatigue, insomnia symptoms, and physical 
functioning reached moderate effect sizes (i.e., between .30-.50; J. Cohen, 1992). In the 
preregistered analyses, the scale showed incremental validity over NEO facets and the 
MAPP predicting insomnia symptoms, physical functioning, pain, general health 
perceptions, energy/fatigue, and the physical health composite score. This was in addition 
to outperforming all other FFAvA scales that also significantly predicted these outcomes 
and were included in the same regression analyses. In the exploratory analyses, the scale 
predicted eight self-report health behavior and perception scales over and above 
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demographic covariates and levels of the health behavior and perception scales at Wave 
1. These findings indicate that the four-item Despair scale is a significant predictor of 
physical health behaviors and perceptions across time in older adults, and a predictor of 
increases in problems in these areas across time.  
Multiple FFMPD scales showed robust relationships with health behaviors and 
perceptions. FFOCI Excessive Worry showed incremental validity over the NEO and 
MAPP predicting insomnia symptoms and pain, and FFOCI Detached Coldness showed 
incremental validity over the NEO and MAPP predicting general health perceptions and 
the physical health composite score. However, these relationships did not remain 
significant when controlling for covariates. FFAvA Joylessness showed moderate effect 
sizes in correlations with informant-reported health status, general health perceptions, 
energy/fatigue, and the physical health composite score, and showed incremental validity 
over the NEO and MAPP in predicting these variables, as well as incremental validity 
over covariates. This more robust result indicates that trait-level joylessness may 
contribute to multiple areas of physical health-related outcomes; and predict increases in 
perceptions of physical health-related problems from both self- and informant-
perspectives.  
Other FFMPD scales that predicted multiple outcomes with incremental validity 
over covariates and/or NEO and MAPP variables included FFBI Self-Disturbance, FFBI 
Despondence, FFBI Behavioral Dysregulation, FFBI Rashness, FFAvA Social Dread, 
FFAvA Evaluation Apprehension, FFAvA Mortified, and FFAvA Shrinking. Some 
FFMPD scales displayed broader relationships with health behaviors and perceptions 
(e.g., Despair associated with most negative health behaviors and perceptions), while 
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others have more specific connections (e.g., Social Dread predicted lower accident 
control and more fatigue). The performance of the FFMPD scales generally provides 
support for the idea that a dimensional framework for studying personality disorder 
improves criterion validity for physical health outcomes.  
While FFAvA Risk Averse showed a significant positive effect for fewer traffic 
accidents at a moderate effect size, it also correlated negatively with physical functioning, 
showing that while a maladaptive conscientiousness behavior may be adaptive in some 
contexts (e.g., inhibition of behavior thereby avoiding risks), it does not come without 
maladaptivity in other contexts. This finding of a positive relationship with traffic 
safety—but negative health perceptions—was replicated by the FFOCI Risk Averse 
scale. Risk aversion may motivate safer driving behaviors, but also drive negative 
perceptions of physical health (in this case, physical functioning). That is, people who 
avoid risk may more anxiously evaluate their health. This unique pattern underscores the 
importance of adopting a dimensional framework, at the facet-level, to examine more 
nuanced relationships between maladaptive personality traits and health.  
The present study benefitted from the inclusion of informant-report measures of 
health behaviors and general health perceptions in addition to self-reports. Targets who 
scored higher on FFOCI Workaholism and FFAvA Joylessness were perceived as less 
healthy by informants, over and above NEO and MAPP scores. The Joylessness 
connection was at a moderate effect size. The results indicate that informants perceive 
people higher on Joylessness as less physically healthy; and perhaps people higher on 
Joylessness are less physically healthy. Results also indicated that target participants who 
rated themselves higher on Risk Averse were rated higher on health behaviors by 
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informants1. These findings are important because they provide multi-method validation 
of FFMPD scales. Future work including informant-reports of the FFMPD scales will be 
especially useful to cross-validate findings of the associations between FFMPD scales 
and health behaviors and perceptions. 
More research is needed on personality and physical health. While the amount is 
increasing, there is still much to learn. In particular, there is very little about maladaptive 
personality traits and physical health. This is a problem especially because maladaptive 
personality may have even stronger relationships with physical health than adaptive-
range personality traits, as evidenced in the present study. Correlations suggested in some 
cases there are moderate-sized effects—that FFMPD traits predict around 10% of the 
variance in a respective physical health indicator. This is a significant amount of 
information about future health markers. There are few other predictors of future physical 
health outcomes that explain more than 10% of the variance in the outcome. This 
indicates that personality could be one (of many) important predictors of physical 
health—especially if facet-level associations are taken into account.  
The present findings provide further evidence that personality should be 
considered in medical settings. Personality assessments in medical care could provide 
useful pieces of information about future medical risk. In addition to gathering more data 
to answer questions about the specific associations between FFMPD and health, this 
raises further questions: for example, how best could measures of personality be 
integrated into healthcare settings, and how best could they be used? While studies have 
 
1 While this is a “positive” relationship, and Risk Averse is a maladaptive trait, this finding still provides 
construct validity evidence for the Risk Averse facet scale. It makes sense that people high on Risk Averse 
would display more positive health behaviors (but high levels of the trait may cause problems in other areas 
of their lives—for example, in the present study, lower self-reported perceptions of physical functioning). 
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begun to consider these issues (Israel et al., 2014), there are more gains to be made and 
issues to consider in order to make use of the research indicating that personality predicts 
health (e.g., assessment choices, length of assessments, cutoff scores, feedback to 
patients, treatment strategies, destigmatization of maladaptive traits). 
4.1 LIMITATIONS 
 The present study provided a first look at the criterion validity of the FFMPD 
scales for the prediction of physical health behaviors, perceptions, and inflammatory 
biomarkers. The study used multi-method assessment and employed a large 
representative community sample of older adults, a population where physical health 
problems become more prominent and where personality-health associations may be 
particularly important to understand. However, it will be important to extend these 
methods to understand relationships between FFMPD and physical health indicators in 
adults of all ages. Future studies could be improved with further multi-method 
assessment and larger sample sizes. In the future, it will be important to obtain informant-
reports of the FFMPD traits—self–other agreement on personality traits is important for 
validating the constructs. Further, it is sometimes the case that informant-reports of 
personality predict important health outcomes that self-reports do not (Klein, 2003; T. W. 
Smith et al., 2007), making it even more important to examine how informant-reports of 
FFMPD traits predict physical health indicators.  
 Additionally, the present study used only three of eight existing FFMPD measures 
(Widiger et al., 2012). The measures used were selected based on prevalence of 
pathology found in the sample at baseline and on the fact that the FFMPD measures 
included in the present study mainly assessed traits unique to neuroticism, extraversion, 
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and conscientiousness, which are the FFM domains most often associated with physical 
health (T. W. Smith et al., 2015). While this was useful for the present study, the full 
range of FFM domains and FFMPD traits should be tested to examine connections with 
physical health.  
 A few of the self-report personality and health scales had low internal 
consistency, which could have affected the results. For example, Substance Risk had a 
coefficient alpha of ~.30. This might reflect the fact that the scale only had 3 items, with 
each assessing a different substance—there was one for alcohol, one for smoking, and 
one for other drugs. Future research would do well to have longer and separate scales for 
each drug of interest. Additionally—while median coefficient alphas for personality 
scales were much higher and psychometrically acceptable—the FFOCI Punctiliousness 
and FFAvA Rigidity scales had the lowest alphas at both waves, at unacceptable levels 
(~.35 and ~.40, respectively). This indicates that perhaps these short-form scale items are 
not homogeneous and should be revised—at least for the assessment of Punctiliousness 
and Rigidity in older adults. These scales also had perhaps the least frequent correlations 
with the outcomes (Substance Risk, another scale with low internal consistency, also had 
few significant correlations with the personality variables), which may have been a result 
of attenuation due to low reliability.  
 Another area for improvement involves the examination of inflammatory 
biomarkers. While the sample size was not a problem for the examination of self-report 
outcomes, the effect sizes of personality predicting biomarkers are smaller, and these 
smaller effects likely require larger sample sizes. This is potentially why there were few 
statistically significant effects of personality predicting biomarkers (using a p value of 
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<.001). The most useful prior studies of FFM traits and biomarkers employed thousands 
of participants. Only using several hundred in the present study (as all participants did not 
consent to the blood draw) may not have provided enough power to tease apart 
significant effects. For this reason, it should not be concluded from the present study that 
the FFMPD traits are not associated with biomarkers in older adults.  
 Finally, future research should examine the mechanisms through which 
personality traits influence physical health-related outcomes. The present study answered 
initial questions about the utility of the FFMPD scales. Data from the present sample are 
still being collected, providing opportunities to examine longitudinal links between 
personality, health behaviors, health perceptions, biomarkers, and outcomes such as 
disease onset and mortality across more than two timepoints in the future. 
4.2 CONCLUSIONS 
Research indicates that personality is an important predictor of physical health. 
The present study is a staging point for continued research on dimensional models of 
maladaptive personality traits and physical health. Results from the present study indicate 
that FFMPD traits predict health behaviors, health perceptions, and biomarkers of 
inflammation, with incremental validity over demographic covariates, normative models 
of personality traits, and DSM personality disorders for predicting health behaviors and 
health perceptions. Continued research in this area will further illuminate associations 
between maladaptive personality and health, and can lead to ideas about how to 
implement personality assessment in healthcare settings. Capitalizing on the connections 
between personality and health may be an important way to eventually maximize 
healthcare providers’ ability to help patients avoid long-term physical health problems.    
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